Focused on developing and commercializing rapid, highly accurate molecular assays for food safety, biopharmaceutical and water testing applications
Location: United States, New Jersey, Stafford Township
Total raised: $67.5M
Investors 3
| Date | Name | Website |
| - | New Enterp... | nea.com |
| - | Aisling Ca... | aislingcap... |
| - | TPG | tpg.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 09.01.2012 | Series D | $47.5M | - |
| 28.07.2011 | Series C | $20M | - |
Mentions in press and media 3
| Date | Title | Description |
| 09.01.2012 | Roka Bioscience Secures $47.5M in Series D Financing | Roka Bioscience, a Warren, N.J.-based company focused on developing and commercializing innovative solutions based on molecular technologies for the industrial markets, has secured $47.5m in Series D financing. The company closed on $27.5m ... |
| 28.07.2011 | Roka Rakes In $20M Series C | The investor syndicate included participation from all existing investors including OrbiMed Advisors, New Enterprise Associates, Inc., TPG Biotech and Gen-Probe. >> Click here for more funding data on Roka Rakes In >> To exp... |
| 28.07.2011 | Roka Bioscience Completes $20M Series C Equity Financing | Roka Bioscience, Inc., a Warren, NJ-based company that focuses on developing and commercializing innovative solutions based on molecular technologies for the industrial markets, has completed a $20m Series C equity financing. Investors incl... |